Paper1733554
Phase I trial of piroxicam in 62 dogs bearing naturally occurring tumors.
Knapp DW and 4 others. Cancer Chemother Pharmacol, 1992. Cited by 96 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Phase I trial of piroxicam in 62 dogs bearing naturally occurring tumors. Papers, record 1733554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1733554
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Dog Diseases | Major topic |
| Neoplasms | Major topic |
| Piroxicam | Major topic |
| Animals | |
| Dogs | |
| Drug Administration Schedule | |
| Drug Evaluation | |
| Female | |
| Male |
Source PubMed
References17
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7,400,257 | Analysis of piroxicam in plasma by high-performance liquid chromatography. | J Chromatogr | 1980 | https://conductscience.org/library/papers/7400257 | PubMed |
| 2 | 3,318,750 | Nonsteroidal anti-inflammatory drug gastropathy. Recognition and response. | Arch Intern Med | 1987 | https://conductscience.org/library/papers/3318750 | PubMed |
| 3 | 12,765 | Piroxicam, a novel anti-inflammatory agent. | Arzneimittelforschung | 1976 | https://conductscience.org/library/papers/12765 | PubMed |
| 4 | 6,345,166 | Piroxicam--a literature review of new results from laboratory and clinical studies. | Eur J Rheumatol Inflamm | 1983 | https://conductscience.org/library/papers/6345166 | PubMed |
| 5 | 6,113,108 | Metabolism of piroxicam by laboratory animals. | Drug Metab Dispos | 1981 | https://conductscience.org/library/papers/6113108 | PubMed |
| 6 | 4,981,040 | Mastocytoma and gastroduodenal ulceration. Gastric and duodenal ulcers in dogs with mastocytoma. | Pathol Vet | 1969 | https://conductscience.org/library/papers/4981040 | PubMed |
| 7 | 6,691,775 | Piroxicam-induced renal disease. | Arch Intern Med | 1984 | https://conductscience.org/library/papers/6691775 | PubMed |
| 8 | 3,652,039 | Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development. | Cancer Res | 1987 | https://conductscience.org/library/papers/3652039 | PubMed |
| 9 | 6,861,813 | Pharmacokinetics of piroxicam in man. | Eur J Rheumatol Inflamm | 1983 | https://conductscience.org/library/papers/6861813 | PubMed |
| 10 | 6,509,432 | Effect of piroxicam on primary intestinal tumors induced in rats by N-methylnitrosourea. | Cancer Lett | 1984 | https://conductscience.org/library/papers/6509432 | PubMed |
| 11 | 6,640,513 | The suppressive effect of piroxicam on autochthonous intestinal tumors in the rat. | Cancer Lett | 1983 | https://conductscience.org/library/papers/6640513 | PubMed |
| 12 | 3,166,075 | Piroxicam inhibits the growth of an adenocarcinoma isograft in Fischer rats. | J Surg Res | 1988 | https://conductscience.org/library/papers/3166075 | PubMed |
| 13 | 2,109,653 | Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug with D,L-alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet. | Cancer Res | 1990 | https://conductscience.org/library/papers/2109653 | PubMed |
| 14 | 3,099,048 | Inhibition of intestinal carcinogenesis in rats: effect of difluoromethylornithine with piroxicam or fish oil. | J Natl Cancer Inst | 1986 | https://conductscience.org/library/papers/3099048 | PubMed |
| 15 | 6,363,936 | Renal syndromes associated with nonsteroidal antiinflammatory drugs. | N Engl J Med | 1984 | https://conductscience.org/library/papers/6363936 | PubMed |
| 16 | 2,819,706 | Prevention and treatment of primary intestinal tumors in rats by piroxicam. | Cancer Res | 1989 | https://conductscience.org/library/papers/2819706 | PubMed |
| 17 | 2,736,316 | [Regression and slowing of the growth of human pulmonary metastases induced by piroxicam, an inhibitor of prostaglandin synthesis]. | Bull Cancer | 1989 | https://conductscience.org/library/papers/2736316 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 96 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,319,213 | Clinical Remission of an Unresectable Presumptive Haemangiosarcoma in a Dog Treated With Toceranib, Piroxicam, and Propranolol: A Case Report. | Vet Med Sci | 2026 | https://conductscience.org/library/papers/42319213 | PubMed |
| 40,351,767 | Identification of metastasis-associated protein 1 (MTA1) as a new molecular marker for canine urothelial carcinoma. | Front Vet Sci | 2025 | https://conductscience.org/library/papers/40351767 | PubMed |
| 38,922,022 | Multimodal Blockade of the Renin-Angiotensin System in the Treatment of Cancer in Dogs Has Mild Adverse Effects in Some Dogs. | Vet Sci | 2024 | https://conductscience.org/library/papers/38922022 | PubMed |
| 37,624,316 | Meloxicam in Combination with Mitoxantrone or Vinblastine as First-Line Treatment for Non-Resectable Urothelial Cell Carcinoma in Dogs. | Vet Sci | 2023 | https://conductscience.org/library/papers/37624316 | PubMed |
| 37,377,896 | Development of an Anti-canine PD-L1 Antibody and Caninized PD-L1 Mouse Model as Translational Research Tools for the Study of Immunotherapy in Humans. | Cancer Res Commun | 2023 | https://conductscience.org/library/papers/37377896 | PubMed |
| 35,893,776 | Canine Gastric Cancer: Current Treatment Approaches. | Vet Sci | 2022 | https://conductscience.org/library/papers/35893776 | PubMed |
| 35,665,759 | Exploration of serum biomarkers in dogs with malignant melanoma receiving anti-PD-L1 therapy and potential of COX-2 inhibition for combination therapy. | Sci Rep | 2022 | https://conductscience.org/library/papers/35665759 | PubMed |
| 33,534,961 | Prevalence of gastrointestinal lesions in dogs chronically treated with nonsteroidal anti-inflammatory drugs. | J Vet Intern Med | 2021 | https://conductscience.org/library/papers/33534961 | PubMed |
| 32,255,906 | In-vitro effects of taurolidine alone and in combination with mitoxantrone and/or piroxicam on canine transitional cell carcinoma. | Can J Vet Res | 2020 | https://conductscience.org/library/papers/32255906 | PubMed |
| 32,039,002 | Naturally-Occurring Invasive Urothelial Carcinoma in Dogs, a Unique Model to Drive Advances in Managing Muscle Invasive Bladder Cancer in Humans. | Front Oncol | 2019 | https://conductscience.org/library/papers/32039002 | PubMed |
| 29,445,618 | Comparative oncology: Integrating human and veterinary medicine. | Open Vet J | 2018 | https://conductscience.org/library/papers/29445618 | PubMed |
| 28,781,660 | Meloxicam decreases the migration and invasion of CF41.Mg canine mammary carcinoma cells. | Oncol Lett | 2017 | https://conductscience.org/library/papers/28781660 | PubMed |
| 27,784,990 | Molecular targets in urothelial cancer: detection, treatment, and animal models of bladder cancer. | Drug Des Devel Ther | 2016 | https://conductscience.org/library/papers/27784990 | PubMed |
| 27,773,993 | Toxico-Neurological Effects of Piroxicam in Monogastric Animals. | J Exp Neurosci | 2016 | https://conductscience.org/library/papers/27773993 | PubMed |
| 26,566,160 | Dogs as a Model for Cancer. | Annu Rev Anim Biosci | 2016 | https://conductscience.org/library/papers/26566160 | PubMed |
| 23,531,445 | Molecular imaging of cyclooxygenase-2 in canine transitional cell carcinomas in vitro and in vivo. | Cancer Prev Res (Phila) | 2013 | https://conductscience.org/library/papers/23531445 | PubMed |
| 23,117,797 | Single-dose safety and pharmacokinetic evaluation of fluorocoxib A: pilot study of novel cyclooxygenase-2-targeted optical imaging agent in a canine model. | J Biomed Opt | 2012 | https://conductscience.org/library/papers/23117797 | PubMed |
| 19,436,636 | Inflammatory mammary carcinoma in 12 dogs: clinical features, cyclooxygenase-2 expression, and response to piroxicam treatment. | Can Vet J | 2009 | https://conductscience.org/library/papers/19436636 | PubMed |
| 18,980,687 | Biphasic pulses enhance bleomycin efficacy in a spontaneous canine genital tumor model of chemoresistance: Sticker sarcoma. | J Exp Clin Cancer Res | 2008 | https://conductscience.org/library/papers/18980687 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1733554
GET https://conductscience.org/api/papers/v1/1733554/authors